These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 4703127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Therapeutic experiences in multiple myeloma].
    Sonntag R, Favre E, Martz G.
    Schweiz Med Wochenschr; 1972 Nov 04; 102(44):1588-9. PubMed ID: 4566555
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of platelet count on haemostatic plug formation and plug stability. An experimental study in rabbits with graded thrombocytopenia.
    Bergqvist D, Arfors KE.
    Thromb Diath Haemorrh; 1973 Dec 31; 30(3):586-96. PubMed ID: 4787674
    [No Abstract] [Full Text] [Related]

  • 6. Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone.
    Kyle RA, Pajak TF, Henderson ES, Nawabi IU, Brunner K, Henry PH, McIntyre OR, Holland JF.
    Cancer Treat Rep; 1982 Mar 31; 66(3):451-6. PubMed ID: 7060034
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The results of a clinical study of asafan].
    Karev NI, Lichinitser MR, Moroz LV, Astrakhan VI, Beroeva GV, Blokhina NG, Buk IM.
    Vopr Onkol; 1970 May 31; 16(5):41-5. PubMed ID: 5450810
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative evaluation of results of treatment of patients with multiple myeloma with fractional doses of sarcolysine and asaline].
    Kruglova GV, Merkulova NV, Panicheva EA.
    Probl Gematol Pereliv Krovi; 1969 Feb 31; 14(2):21-4. PubMed ID: 5351083
    [No Abstract] [Full Text] [Related]

  • 10. Phase II evaluation of mitozolomide in ovarian cancer.
    Harding M, Northcott D, Smyth J, Stuart NS, Green JA, Newlands E.
    Br J Cancer; 1988 Jan 31; 57(1):113-4. PubMed ID: 3348943
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of myeloma].
    Le Chevallier PL.
    Therapeutique; 1971 Jan 31; 47(6):627-9. PubMed ID: 5571183
    [No Abstract] [Full Text] [Related]

  • 12. Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol).
    Tirelli U, Crivellari D, Carbone A, Veronesi A, Galligioni E, Trovò MG, Tumolo S, Grigoletto E.
    Cancer Treat Rep; 1982 Nov 31; 66(11):1971-3. PubMed ID: 6897205
    [Abstract] [Full Text] [Related]

  • 13. Treatment of multiple myeloma.
    Langley GR, Smith FM.
    N S Med Bull; 1967 May 31; 46(5):105-8. PubMed ID: 5232995
    [No Abstract] [Full Text] [Related]

  • 14. [The morphologic composition of peripheral blood following intra-arterial infusion of 5-fluorouracil and alkylating preparations in stomach cancer patients].
    Chernyĭ VA.
    Vopr Onkol; 1970 Apr 31; 16(4):61-4. PubMed ID: 4989339
    [No Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy of advanced murine myeloma and subsequent resistance to tumor cell challenge.
    Teller MN, Bowie M, Mountain IM, Stock CC.
    J Natl Cancer Inst; 1974 Mar 31; 52(3):667-71. PubMed ID: 4857022
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of a new cytostatic agent (peptichemio) on malignant neoplasms].
    Pittermann E, Stacher A, Griendl W.
    Wien Med Wochenschr; 1974 Apr 06; 124(14):216. PubMed ID: 4522966
    [No Abstract] [Full Text] [Related]

  • 17. A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder.
    Blackledge G, Roberts JT, Kaye S, Taylor R, Williams J, de Stavola B, Uscinska B.
    Eur J Cancer Clin Oncol; 1989 Feb 06; 25(2):391-2. PubMed ID: 2702992
    [No Abstract] [Full Text] [Related]

  • 18. Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.
    Pönisch W, Rozanski M, Goldschmidt H, Hoffmann FA, Boldt T, Schwarzer A, Ritter U, Rohrberg R, Schwalbe E, Uhlig J, Zehrfeld T, Schirmer V, Haas A, Kreibich U, Niederwieser D, East German Study Group of Haematology and Oncology (OSHO).
    Br J Haematol; 2008 Oct 06; 143(2):191-200. PubMed ID: 18752593
    [Abstract] [Full Text] [Related]

  • 19. [Results of 18 months of chemotherapy with Peptichemio].
    Battelli T, Bonsignori M, Manocchi P, Perilli A.
    Minerva Med; 1974 Sep 08; 65(62):3235-43. PubMed ID: 4609310
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of severe spastic forms of bronchitis with nitrogen mustard].
    Romański B, Montowska L.
    Pol Tyg Lek; 1974 Jun 03; 30(22):931-3. PubMed ID: 4840193
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.